This message was sent to ##Email##
|
|
|
|
|
The Wall Street Journal
When Al Piazza learned he had prostate cancer, his first thought was, "Let's get this out and be done with it," he says. But his urologist, Jeremy Lieb, said the side effects of treatment could be more harmful than the cancer itself.
Dr. Lieb ran a genetic test on the patient's biopsy sample, which calculated that Piazza, then 70 years old, had only a 3 percent chance of dying from prostate cancer over the next 10 years if he left the tumor untreated.
Four years later, the retired AT&T manager from Discovery Bay, California, has been monitoring his cancer with regular blood tests and imaging scans and says he is comfortable leaving it alone.
READ MORE
ScienceDaily
Small, non-coding molecules called microRNAs are known to play an important role in cancer development. Researchers now have shown their significance is greater than previously thought, a finding that could lead to new therapeutic approaches for the most common and deadly form of ovarian cancer.
READ MORE
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
ACS
On-site registration is available for the NAPBC Best Practices Conference, May 13-14 being held at the B. Resort & Spa 1905 Hotel Plaza Blvd. Lake Buena Vista, Florida. Hear innovative and efficient methodologies that have been implemented in 15 NAPBC-accredited breast centers and learn how you can adapt these practices within your own facility.
Registration will be open from noon to 6:30 p.m. on Friday, May 13 and from 7 to 8 a.m. on Saturday, May 14. For information, contact the NAPBC.
Modern Healthcare
In 2015, Philadelphia boasted one of the highest breast cancer screening rates in Pennsylvania. It ranked third among the 10 largest U.S. cities with 82 percent of women age 50 to 74 having received a mammogram in the previous two years, according to the city's community health assessment. While good news for the city, the incidence and outcomes data generated by the screening campaign painted a harrowing picture for at least one subpopulation: Women from west Philadelphia had the highest breast cancer mortality rate in the city and surrounding suburban areas, despite lower rates of the disease.
READ MORE
Advertisement
 |
|
When it comes to inheritable health conditions, accessing the right genetics care for the right person in the right setting at the right cost is critical for optimal outcomes. MORE
|
|
ACS
The 15 scheduled Meet-the-Expert Luncheons per day at Clinical Congress 2016, Oct. 16−20 in Washington, D.C., will feature several general surgery topics of interest. The $45 fee includes a box lunch and beverage and the opportunity to informally discuss topics of interest with an expert and colleagues. The luncheons will offer one hour of Continuing Medical Education Credit.
READ MORE
The 2016 Commission on Cancer (CoC) Annual Conference provides a comprehensive look at CoC standards and the National Cancer Database (NCDB) tools and resources. On June 1 and 2, the CoC Program: Pathway to Quality Cancer Care will focus on the CoC Standards and the value of various roles on the cancer committee, guiding participants toward a first-rate quality cancer care program. The NCDB Workshop: Utilizing the NCDB for Quality Improvement on June 3 will provide an in-depth look at the use of the NCDB tools as well as best practices to maximize your cancer program's data. Developed by CoC and NCDB staff and committee leadership, these programs address a cancer program's common questions and concerns regarding CoC standards and compliance as well as the skills and knowledge needed to lead quality improvement initiatives using NCDB tools.
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
University of Pennsylvania School of Medicine via Medical Xpress
Running large, multi-gene sequencing panels to assess cancer risk is a growing trend in medicine as the price of the technology declines and more precise approaches to cancer care gain steam. The tests are particularly common among breast and ovarian cancer patients. However, questions remain about the growing list of mutations and their suspected, but unproven association with breast and ovarian cancer risk.
READ MORE
White House
Early this year, President Barack Obama announced the establishment of a new National Cancer Moonshot Initiative to accelerate cancer research. Led by Vice President Joe Biden, the goal of the initiative is to make decades worth of advancements within five years (in other words, making more therapies available to more patients and improving our ability to prevent cancer and detect it at an early stage).
The National Cancer Institute (NCI) is supporting this initiative by asking members of the scientific community and the general public for their ideas on how to advance cancer research. Be a part of National Cancer Moonshot Initiative and encourage your staff and community to submit their scientific ideas.
|
|
Advertisement
 |
|
For the past 22 years, EduCare's mission has been to support Healthcare Professionals in educating breast cancer patients. We strive to offer products that are patient-friendly and up-to-date. Patient education increases compliance, reduces time constraints and promotes a partnership between patient and healthcare providers.
|
|
|
|
|
Advertisement
 |
|
Specialty Practice Management is a complete front- and back-office solution that offers a rapid return on your investment and improved satisfaction among your staff. Practices with 10 or fewer providers turn to this comprehensive solution to manage self-pay accounts and eliminate common mistakes.
|
|
|
|
PR Newswire
In recognition of Nurses Appreciation Week, Stand Up To Cancer (SU2C) announces the development of a series of Certification for Nursing Education (CNE) training modules by experts from Boston College William F. Connell School of Nursing. The CNE modules will equip nurses with the skills and knowledge needed to manage the unique challenges and patient symptoms that accompany administration of emerging immunotherapies to treat cancer. The first of a series of the three web-based SU2C-Boston College Immunotherapy CNE modules will be available to nurses in July 2016.
READ MORE
ACS
June 5 marks the 29th Annual National Cancer Survivors Day, which brings cancer survivors together to show that there is life after receiving a diagnosis of cancer. The Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC) encourage your program to observe this day and use it as an opportunity to display/promote your CoC and NAPBC accreditation status. To help you promote this event within your program and the community, the CoC and the NAPBC have developed a poster that you can download and print. Programs that hold CoC accreditation or have both CoC and NAPBC accreditations can access the poster by going to CoC Datalinks and clicking on Marketing Resources. For programs that are solely NAPBC accredited, please use the link to the Marketing Resources website provided in your performance report email notification. For more information, contact srubin@facs.org.
Oncology Nursing Society
In March 2016, the Oncology Nursing Society in conjunction with the Oncology Nursing Certification Corporation completed a study focused on the role of nurse navigators in oncology settings. Compared with a previous study conducted in 2011, the new Nurse Navigator Role Delineation Study yielded insightful information as to how the position of nurse navigator has grown and evolved since the 2011 study.
Approximately 500 nurse navigators responded to the survey. Results indicated that the nurse navigator role has become more defined in recent years. More nurses have assumed the title of nurse navigator, and the position is being implemented at most cancer sites.
READ MORE
Medscape
The Joint Commission, which accredits most U.S. hospitals as well as other healthcare organizations, has rescinded a five-year ban on the texting of orders. "Effective immediately, The Joint Commission has revised its position on the transmission of orders for care, treatment and services via text messaging for all accreditation programs," according to a statement published in the May issue of Joint Commission Resources.
READ MORE
HealthNewsReview
Colon cancer is on the decline, and you'd be forgiven for thinking that colon cancer screening — and the increased adoption of colonoscopies in particular — is the reason.
Promotion of colonoscopies, a market worth more than $10 billion annually in the United States, is everywhere.
READ MORE
If you are a Cancer Liaison Physician, plan to join us at a special CoC-CLP Breakfast from 6:30–7:30 a.m. on
Monday, June 6 at the Hyatt Regency McCormick Place, Chicago. To register, send your name and email address to clp@facs.org by May 20.
For additional information, please complete the mailing list request form.
|
|
|
Advertisement
Advertisement
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
